Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia

BACKGROUND: This 13-week, double-blind study was conducted to confirm the efficacy and safety of paliperidone palmitate (PP), at dosing regimens approved in other countries, in Asian patients with schizophrenia. METHODS: Asian patients (aged ≥20 years) diagnosed with schizophrenia (Diagnostic and St...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Nagahide, Takahashi, Masayoshi, Saito, Takayuki, Iizumi, Misuzu, Saito, Yuki, Shimizu, Hiroko, Matsumura, Taka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862510/
https://www.ncbi.nlm.nih.gov/pubmed/24353421
http://dx.doi.org/10.2147/NDT.S54051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862510/
https://www.ncbi.nlm.nih.gov/pubmed/24353421
http://dx.doi.org/10.2147/NDT.S54051

Ejemplares similares